Company Encyclopedia
View More
name
HAINAN HAIYAO
000566.SZ
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers intermediates, active pharmaceutical ingredients (APIs), innovative chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, cell immunotherapy, and medical devices, as well as big health category products, digestive and anti-infective products, breathing products, anti-tumor products, chronic disease category products, vitamins, Chinese herbal medicine slices, and medical services. Hainan Haiyao Co., Ltd.
3.157 T
000566.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
E
PharmaceuticalsIndustry
Industry Ranking222/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-143.97%E
    • Profit Margin-178.32%E
    • Gross Margin19.62%D
  • Growth ScoreE
    • Revenue YoY-19.89%E
    • Net Profit YoY-290.40%E
    • Total Assets YoY-20.56%E
    • Net Assets YoY-82.91%E
  • Cash ScoreD
    • Cash Flow Margin-56.08%D
    • OCF YoY-19.89%E
  • Operating ScoreE
    • Turnover0.13E
  • Debt ScoreE
    • Gearing Ratio94.43%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    November 26th Midday Review: The ChiNext Index rose 2.76% in half a day, with CPO and pharmaceutical stocks collectively strengthening

    On November 26th at noon, the ChiNext Index rose by 2.76%, with CPO and pharmaceutical stocks collectively strengthening. The Shanghai Composite Index fluctuated narrowly, with Zhongji Innolight rising over 10%, reaching a historical high. Pharmaceutical stocks such as Huaren Health and HAINAN HAIYAO saw multiple stocks hitting the daily limit. The military industry sector adjusted, with Jiuzhiyang and Jianglong Shipbuilding falling over 10%. Nearly 3,000 stocks in the Shanghai, Shenzhen, and Beijing markets were in the green, with a morning trading volume of 1.14 trillion

    Wallstreetcn·
    SZ
    000566
    +0.62%
    SZ
    300308
    +0.29%
    Wallstreetcn·
    SZ
    000566
    +0.62%
    SZ
    300308
    +0.29%

    In half a day, the main funds increased their positions in the media sector and sold off the non-ferrous metals sector

    In the morning, the main funds had a net inflow into sectors such as media, agriculture, forestry, animal husbandry, and fishery, while there was a net outflow from sectors like non-ferrous metals, power equipment, and electronics. Specifically, in terms of individual stocks, RONGJI SOFTWARE, HAINAN HAIYAO, and KAIMEITE GASES saw net inflows of 1.377 billion yuan, 1.238 billion yuan, and 1.060 billion yuan, respectively. On the net outflow side, Zhongji Xuchuang, Aerospace Development, and Tianqi Lithium were sold off for 1.550 billion yuan, 1.251 billion yuan, and 1.179 billion yuan, respectively. (First Financial)

    36Kr·
    SZ
    002474
    +4.17%
    SZ
    000566
    +0.62%
    SZ
    002549
    -0.69%
    36Kr·
    SZ
    002474
    +4.17%
    SZ
    000566
    +0.62%
    SZ
    002549
    -0.69%

    Hainan Haiyao Subsidiary Gets China Supplementary Nod for Antibiotic

    Hainan Haiyao Subsidiary Gets China Supplementary Nod for Antibiotic

    marketscreener·
    SZ
    000566
    +0.62%
    marketscreener·
    SZ
    000566
    +0.62%

    Hainan Haiyao's subsidiary has obtained the drug registration approval for Fumaric Acid Vorinostat Tablets

    According to the Zhitong Finance APP, HAINAN HAIYAO announced that its wholly-owned subsidiary Haikou Pharmaceutical Factory Co., Ltd. recently obtained the "Drug Registration Certificate" for the chemical drug "Fumaric Acid Vonoprazan Tablets" issued by the National Medical Products Administration. The registration certificate states that the indication is: reflux esophagitis. It is used in combination with appropriate antibiotics to eradicate Helicobacter pylori

    Zhitong·
    SZ
    000566
    +0.62%
    Zhitong·
    SZ
    000566
    +0.62%

    HAIAN HAIYAO: Net loss of 84.002 million yuan in the third quarter

    HAIAN HAIYAO announced that its revenue for the third quarter was 189 million yuan, a year-on-year decrease of 10.36%; the net profit loss was 84 million yuan. Revenue for the first three quarters was 640 million yuan, a year-on-year decrease of 20.51%; the net profit loss was 242 million yuan

    Zhitong·
    SZ
    000566
    +0.62%
    Zhitong·
    SZ
    000566
    +0.62%
    © 2025 Longbridge｜Disclaimer